Valuation (76%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.12 | 13.53 |
PEG Ratio (TTM) | 1.07 | 2.90 |
P/S Ratio (TTM) | 1.38 | 1.60 |
P/B Ratio (TTM) | 1.07 | 2.76 |
P/FCF Ratio (TTM) | 7.77 | 7.41 |
Price to 5YR AVG Earnings Ratio | 29.86 | 20.46 |
Price to 5YR AVG FCF Ratio | 9.46 | 11.84 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.00% | 4.45% |
ROE (TTM) | 10.20% | 21.63% |
Net Profit Margin (TTM) | 12.49% | 11.44% |
ROIC 5YR AVG | -5.97% | 10.32% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 17.93% | 12.33% | 15.72% |
Revenue | -18.53% | 0.29% | 2.40% |
Net Income | 17.04% | 9.67% | 11.22% |
Cash Flow | 5.42% | -2.74% | 7.20% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.02 | 21.95 |
Quick Ratio (TTM) | 0.02 | 21.95 |
D/E Ratio (TTM) | 0.55 | 0.38 |
Interest Coverage (TTM) | 3.34 | 19.77 |
Piotroski F-Score | 7 | 7 |
Altman Z-Score | 0.36 | 1.64 |
LTL to 5YR AVG FCF | 4.06 | 1.40 |
Shares Outstanding Growth 5YR AVG | -6.54% | -2.24% |